Sodium-glucose cotransporter-2 inhibitor use in patients with a Fontan circulation
This series, the largest published to date, suggests that sodium-glucose cotransporter-2 inhibitors are safe and tolerable congestive heart failure therapy in Fontan circulation. Further research is warranted to explore therapy in this unique population.
Authors
- Rochelle N. Judd
- Frances K. Woodard
- Thomas Brenzel
- Andrew Savage (ORCID: https://orcid.org/0000-0002-0422-1121)
- Heather Henderson
- Kimberly E. McHugh (ORCID: https://orcid.org/0000-0001-8329-5411)
- Andrew M. Atz (ORCID: https://orcid.org/0000-0002-4744-3832)
- Stephanie Gaydos
- David Gregg (ORCID: https://orcid.org/0000-0003-4998-4234)
Institutions
- Medical University of South Carolina (US)
Publication Details
- Journal
- Cardiology in the Young
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1017/s1047951125000514
- Citations
- 7
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 9.72